免疫球蛋白G4相关眼病的眼表评估
这项横断面匹配病例对照研究纳入64例活检确诊的IgG4相关眼病(IgG4-ROD)患者和64例性别年龄匹配的健康对照,评估睑板腺与眼表的功能和结构改变。结果显示IgG4-ROD患者同时具有水液性泪液缺乏和蒸发过强型干眼特征,作者推荐对所有新诊断IgG4-ROD患者进行眼表评估。
要点
- IgG4-ROD患者角膜荧光素染色、睑缘毛细血管扩张、睑板腺开口堵塞等眼表异常较健康对照更显著。
- IgG4-ROD患者上下睑板腺缺失及泪河高度高于对照,非侵入性泪膜破裂时间和Schirmer试验结果低于对照。
- 影像学上有泪腺增大的IgG4-ROD眼非侵入性泪膜破裂时间低于无泪腺增大者(P < .0001)。
核心结论
- IgG4-ROD患者同时表现出水液性泪液缺乏和蒸发过强型干眼病的特征。
- 作者推荐对所有新诊断的IgG4-ROD患者进行眼表评估。
- 作者认为需进一步研究以阐明IgG4相关干眼病的机制。
研究设计与样本
- 横断面、匹配病例对照比较研究,纳入64例活检确诊的IgG4-ROD患者(年龄63.4 ± 12.2岁,39例男性)和64例性别年龄匹配的健康对照。
- 患者由覆盖香港公共资助眼科服务的医院管理,评估包括眼前段检查、角膜地形图和睑板腺成像。
主要发现
- IgG4-ROD患者较健康对照更显著的指标:角膜荧光素染色(P = .0187)、睑缘毛细血管扩张(P = .0360)、睑球平行结膜皱褶(P = .0112)、乳头(P = .0393)、睑板腺开口堵塞(P = .0001)、睑板腺可表达性(P = .0001)、睑脂质量(P = .0001)。
- IgG4-ROD患者上睑板腺缺失(P = .001)和下睑板腺缺失(P = .0003)及泪河高度(P = .0001)均高于健康对照。
- IgG4-ROD患者非侵入性泪膜破裂时间(P = .0166)和Schirmer试验结果(P = .0243)均低于健康对照。
- 上睑板腺缺失与IgG4-ROD发病年龄呈正相关(r = 0.336,P = .0140),非侵入性泪膜破裂时间与发病年龄呈负相关(r = -0.293,P = .0497)。
- 眼外器官受累数量与Schirmer试验呈负相关(r = -0.341,P = .0167);影像学上有泪腺增大的IgG4-ROD眼非侵入性泪膜破裂时间低于无泪腺增大者(P < .0001)。
临床怎么用
- 作者推荐对所有新诊断的IgG4-ROD患者进行眼表评估。
局限性
- 作者认为需进一步研究以阐明IgG4相关干眼病的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the functional and structural changes of the meibomian glands and ocular surface in immunoglobulin G4-related ophthalmic disease (IgG4-ROD) patients. DESIGN: Cross-sectional, matched case-control comparison study. METHODS: This study included 64 patients with biopsy-proven IgG4-ROD (aged 63.4 ± 12.2 years, 39 male) and 64 sex- and age-matched healthy controls. Patients were managed by hospitals covering the publicly funded ophthalmology service in Hong Kong. Outcome measures included anterior segment examination and keratographic and meibographic imagings. RESULTS: A total of 64 worst-affected eyes of the 64 IgG4-ROD patients were analyzed. Corneal fluorescein staining (P = .0187), lid margin telangiectasia (P = .0360), lid-parallel conjunctival folds (P = .0112), papillae (P = .0393), meibomian gland plugging (P = .0001), meibomian gland expressibility (P = .0001), and meibum quality (P = .0001) were more significant in IgG4-ROD patients compared with healthy controls. Both upper and lower meibomian gland dropouts (P = .001 and .0003), and tear meniscus height (P = .0001) were higher in IgG4-ROD patients. Non-invasive tear break-up time (NITBUT) (P = .0166) and Schirmer test results (P = .0243) were lower in IgG4-ROD patients. Upper (r = 0.336, P = .0140) meibomian gland dropouts and NITBUT (r = -0.293, P = .0497) were positively and negatively correlated with the IgG4-ROD onset age, respectively. The number of extraocular organ involvement was negatively correlated with the Schirmer test(r = -0.341, P = .0167). Lower NITBUT was found in IgG4-ROD eyes with lacrimal gland enlargement than in IgG4-ROD eyes without lacrimal gland enlargement radiologically (P < .0001). CONCLUSIONS: IgG4-ROD patients showed features of both aqueous tear deficiency and evaporative dry eye disease. We recommend ocular surface evaluation to all patients newly diagnosed with IgG4-ROD. Further studies are warranted to clarify the mechanism of IgG4-related dry eye disease.
引用
- Lai KKH, Liao X, Aljufairi FMAA, et al. Ocular Surface Evaluation in Immunoglobulin G4-Related Ophthalmic Disease. Am J Ophthalmol. 2023. PMID: 37544494. doi:10.1016/j.ajo.2023.07.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。